Tradestie Institutional Equity Comparison Engine

MESO vs MNKD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MNKD Overall Edge

MNKD Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mannkind Corporation (MNKD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MESO trades at N/M Forward P/E with -42.6% operating margin (+390.7% YoY revenue) versus MNKD at 26.2x Forward P/E and -3.4% operating margin (+24.0% YoY). In options structure, MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro) against MNKD sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner MNKD
MESO N/M vs MNKD 26.2x Fwd P/E
Growth & Margin Winner MNKD
Op Margin -42.6% vs -3.4% ยท YoY +390.7% vs +24.0%
Momentum & Technical Winner MNKD
1Y -16.4% vs -22.9% ยท 52W Pos 6% vs 39%
Options & Structure Winner MNKD
UNCLASSIFIED (37th %ile IV) vs CONSOLIDATION (7th %ile IV)
MESO NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap $1.7B
1M Return -6.1%
1Y Return -16.42%
Forward P/E N/M
Unified AI Score
34.6 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 50.0
MNKD NASDAQ
Mannkind Corporation
Pharmaceutical Preparations
$3.91
-5.33% 1D
Market Cap $1.3B
1M Return +28.62%
1Y Return -22.88%
Forward P/E 26.2x
Unified AI Score
36.1 / 100 SELL
Tech 50.0 Fund 38.0 Flow 72.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MESO -16.42% MNKD -22.88% Spread: +6.46 pp (MESO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MESO TTM Op. Margin: -42.6% MNKD TTM Op. Margin: -3.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MESO vs MNKD. Trailing 12-month operating profitability (MESO -42.6% vs MNKD -3.4%) and valuation multiples (MESO N/M vs MNKD 26.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MESO (2) vs MNKD (8)
Institutional Metric MESO MNKD Criterion Row Winner
Market Capitalization Scale $1.7B $1.3B Larger Scale MESO
Trailing P/E Ratio Valuation N/M 32.3x Lower Multiple MNKD
Forward P/E Ratio Valuation N/M 26.2x Lower Multiple MNKD
Revenue Growth (YoY) Growth +390.7% +24.0% Higher Growth MESO
Operating Margin (TTM) Profitability -42.6% -3.4% Higher Margin MNKD
Net Profit Margin Profitability -47.8% -18.1% Higher Margin MNKD
Return on Equity (ROE) Capital Efficiency -9.9% 0.0% Higher ROE MNKD
52-Week Range Position Momentum 6% ($12โ€“$22) 39% ($2โ€“$7) Stronger Trend MNKD
Beta / 30D Volatility Risk Regime 1.18ฮฒ ยท 78% Vol 1.29ฮฒ ยท 48% Vol Lower Realized Risk MNKD
Unified Institutional Score Composite Signal 34.6 / 100 (SELL) 36.1 / 100 (SELL) Higher Composite MNKD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MESO vs MNKD Buy Guide
MESO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 37th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MESO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MNKD CONSOLIDATION
95d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live MNKD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MESO nor MNKD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.